Reading Between the Lines: How to Evaluate Decontamination Cycle Time Claims
Cycle time is one of the first numbers a prospective isolator buyer asks for, and one of the least comparable numbers a supplier will give them. Two vendors can quote "15 minutes" and "30 minutes", to “60 minutes” or considerably more for functionally similar machines simply because they are measuring different things. Hydrogen-peroxide biodecontamination process development indicates that isolator bio-decontamination processes commonly range from roughly one to four hours depending on chamber size, load, and technology, while aeration alone can be the majority of that time. They have simply drawn the boundaries of the word "cycle" in different places, tested against different endpoints, and run their demonstrations under different conditions.
The risk is that the number does not stay on the sales sheet. It migrates into the user requirement specification, then into the capacity model, then into a batch schedule that assumes a turnaround the equipment was never qualified to deliver. By the time the gap becomes visible, usually during site qualification, with a validation team and a project deadline already committed, the options for fixing it are expensive. It is worth understanding what sits behind the figure while the purchase order is still a draft.
Confirm whether the platform is standard or custom
A quoted cycle time is only as transferable as the chamber it was demonstrated on. Standard, off-the-shelf isolator platforms accumulate a body of cycle data over repeated builds, because the chamber geometry, port locations, and internal fixtures stay consistent from unit to unit. A customized isolator, or a new platform designed around a client's specific process with different chamber dimensions, additional ports, internal fittings will change the internal airflow pattern, the surface area available for peroxide to absorb into and desorb from, and the distances gas has to travel to reach hard-to-reach locations. All of these directly affect the decontamination profile, meaning a cycle time developed on a standard platform is not automatically valid for a customized or first-of-a-kind design. Ask the supplier whether the quoted figure comes from a standard platform with an established track record or from a design that is new or substantially modified for your application, and if it's the latter, whether cycle development and requalification are included in the timeline and cost you've been quoted.
Ask where the clock starts and stops
Hydrogen peroxide decontamination technologies differ in how the decontaminating agent is introduced into the chamber, and this directly shapes cycle time. Atomized (aerosolized) hydrogen peroxide systems typically do not require an extensive dehumidification phase, whereas vaporized hydrogen peroxide (VHP) systems require conditioning to bring chamber relative humidity down to a target range, often 10–20%, before vapor injection can begin. A typical vaporized hydrogen peroxide cycle has distinct phases beyond conditioning: injection/gassing while maintaining certain peroxide concentration, and aeration. Each behaves differently. Conditioning depends on how far the chamber's starting humidity sits from the target and on how much residual moisture the cleaning process leaves behind. Injection/gassing are governed by the concentration profile the generator can hold and by the kill kinetics needed at the hardest location in the chamber. Aeration is usually the longest phase of all, and it is governed less by design intent than by physics: hydrogen peroxide absorbed into the load and into the chamber's own polymer surfaces desorbs gradually. Engineering choices such as catalytic converters that actively decompose the residual gas, or higher air-exchange rates can shorten this phase, but the underlying absorption/desorption behavior is highly case-dependent, and no single design eliminates it.
Because aeration dominates, it is the phase most often left out from a headline claim. Some quotes cover gassing and dwell only. Others stop the clock when aeration reaches a convenient concentration rather than the one the operation actually needs.
Ask for a phase-by-phase breakdown with the duration of each, and ask specifically how aeration is achieved. Recirculating systems with catalytic converters remove hydrogen peroxide differently from single-pass systems that continuously exhaust chamber air to the facility HVAC, and the two scale differently with chamber volume. Single-pass systems can often achieve shorter aeration times through continuous dilution, but they demand a significantly higher airflow and can carry higher operating costs, for example more frequent filter replacement. Recirculating systems generally place lower demand on facility HVAC but may need longer aeration, particularly in larger chambers. In other words, the achievable cycle time is not purely a function of the decontamination technology; it is also a function of the facility's HVAC capability and the airflow configuration selected. It is worth surfacing as a trade-off rather than assuming one architecture is simply "faster."
The path the decontaminating agent takes to reach the chamber is a further source of variation. Some systems introduce hydrogen peroxide directly into the chamber through in-chamber nozzles, decontaminating the working space itself. Others route the sterilant through the supply HEPA or ULPA filter as part of the cycle, so that the filter media is decontaminated along with the chamber, typically because the risk assessment calls for sterility assurance further upstream in the air supply, not just at the point of use. Where that's the case, cycle time is usually longer, because hydrogen peroxide vapor has to permeate the filter media itself before reaching the chamber, and filter media can absorb and later desorb peroxide much as other porous materials do, extending both gassing and aeration. Neither approach is inherently better; they address different points in the air path. But it does mean cycle times between the two are not directly comparable; ask whether the quoted figure includes filter decontamination, and whether that scope matches what your risk assessment actually requires.
Then clarify what falls outside the cycle entirely. Chamber loading, glove integrity testing, pre-cycle leak tests, surface drying after wet cleaning, and post-cycle recovery to ISO 5 particle counts do not appear in a cycle time claim, and all of them consume the same shift. So do ancillary spaces. Establish whether passthrough chambers, rapid transfer port canisters, mouse holes, and any secondary chambers are decontaminated within the quoted cycle or run separately, and whether those separate cycles can overlap with the main one or have to be sequenced around it.
Pin down the aeration endpoint
"Aerated" is not a fixed state; it is a threshold someone has chosen. Confirm the target concentration. One part per million is the common reference point, derived from occupational exposure limits for hydrogen peroxide as an eight-hour time-weighted average, but some suppliers quote to a higher value, and some processes need considerably lower. Products sensitive to peroxide residuals, such as many biologics, some cell and gene therapy products, and certain lyophilized formulations, may need an endpoint driven by product quality rather than operator safety, and that endpoint can be an order of magnitude below the exposure limit. If the relevant limit is set by your product rather than by your operators, the supplier's standard cycle may not be relevant at all.
Then ask three follow-up questions: where is the sensor located, what type is it, and how many measurement points were used? An electrochemical sensor sampling from an exhaust duct will reach the target well before a probe positioned in a stagnant corner of the chamber, behind a pump skid. Sensor range matters as much as sensor location. Some sensors are designed primarily for monitoring higher concentrations during gassing and dwell, with accuracy specified as a percentage of reading; near a low single-digit ppm endpoint, that kind of specification can translate into several ppm of real uncertainty, which is enough to call "aerated" earlier than the chamber actually is. Sensors designed and calibrated specifically for low-level detection, with fine resolution in the sub-5-ppm range, are built to resolve the endpoint itself rather than the gassing phase and behave differently in exactly the region where the aeration claim is being made. Ask what sensor range the reported endpoint was actually measured on, not just what sensor was used for the cycle overall, a supplier may run one sensor for gassing and dwell and a different one for the aeration endpoint, and the second one is the one that matters for the claim you're being given.
It is also worth asking whether the endpoint was reached or held. A concentration that dips below the threshold and rebounds as absorbed peroxide continues to desorb is not the same as a chamber that is stably aerated and ready for aseptic work.
Ask what was in the chamber
Cycle times are often developed with an empty chamber, because that is the configuration that produces the best number and is fastest to demonstrate in a vendor workshop. Real loads change the picture significantly. Peroxide is absorbed by, and slowly released from, a wide range of process materials: stopper bowls, nested syringe and vial tubs, Tyvek lidding, silicone and thermoplastic tubing, filter housing, gloves and sleeves, and anything cellulosic. These act as reservoirs that extend aeration disproportionately to their size. At the same time, filling needles, pumps, guarding, trolleys, and stoppering equipment create shadowed surfaces and stagnant pockets that lengthen the kill phase.
The load pattern matters as much as the load list. The same items arranged differently can change both distribution during gassing and desorption during aeration. So the question to put to the supplier is not simply whether the cycle was run with a load, but whether it was demonstrated with a worst-case load representative of your process, in a worst-case load pattern, and whether they will commit to re-demonstrating it with your actual equipment list once that list is fixed.
Check the microbiological basis
A fast cycle that achieves a 6-log reduction of Geobacillus stearothermophilus at a handful of accessible locations is not, on its own, a robust basis for comparison. It reflects performance under the conditions tested, and equipment condition changes with age. Look for:
- The number and mapping of biological indicator positions, including genuinely hard cases: glove fingertips, RTP port surfaces, mouse holes, undersides of equipment, beneath HEPA face, drain areas, hinge points, and the interiors of any enclosed fixtures. Ask how the worst-case positions were identified, whether by airflow modeling, by prior empirical work, or by assumption.
- Whether the claim rests on cycle development work or on full validation. A development cycle run with a reduced BI set is useful evidence, but it is not the same as a qualified cycle, and it should not be presented as one.
Enzyme indicators are valuable for rapid feedback during development and can shorten the iteration loop considerably, but they need correlation to biological indicator data before they can support a cycle time claim.
Ask about run-to-run consistency
A single best run tells you what the equipment can do under ideal conditions; it does not tell you what to expect routinely. Where available, ask for cycle traces from more than one run rather than a single datasheet figure, together with a description of how consistency between runs is assessed. What you are looking for is a sense of how much variation exists between runs, and how the process holds up against the acceptance limit, recognizing that the depth of run-to-run data available will vary by supplier and by how far a given cycle is through development.
Cycle performance can be sensitive to inlet air temperature and humidity, chamber temperature, peroxide solution concentration and age, and vaporizer output consistency. How much this matters in practice depends heavily on system design. Where chamber conditioning relies substantially on facility supply air, ambient variability can meaningfully affect performance, and it is worth asking whether performance was demonstrated across the ambient range your facility actually experiences. Where a system instead uses active chamber conditioning, for example, chamber heating combined with a dry, compressed air supply rather than reliance on raw facility air that dependency on ambient swings is reduced. Ask the supplier which category their system falls into and what conditioning approach it uses, rather than assuming one answer applies to every design.
Understand what the number commits to
A cycle time figure quoted in a proposal and a cycle time figure demonstrated on your production floor are not typically the same thing. Utilities, room conditions, load, and operator practice all differ between a supplier's workshop and your facility, so a number shown at factory acceptance is a starting point, not proof of what you'll see at site acceptance. It's worth understanding, before contract award, how the supplier proposes to demonstrate the figure on your equipment with your load and whether that verification happens at the factory, at your site, or both.
It's also worth asking early how the figure is expected to hold up over time and through routine changes: consumable replacement, minor load additions, a different glove material. Not every supplier treats cycle time the same way, for some it's closer to a target validated once and reassessed periodically, for others it functions more like a specification. Understanding which one you're being offered, and what re-verification looks like if your process changes, is more useful going into a purchase order than assuming the number is fixed.
Recognize what speed costs
In vaporized and atomized, cycle parameters chosen to shorten gassing/injection for example, utilize higher peroxide injection rates or micro-condensation approaches that improve sporicidal contact and can improve kill speed, but the same higher exposure typically extends the aeration burden and accelerates wear on gaskets, gloves, polycarbonate and acrylic panels, adhesives, printed labels, and elastomeric seals. That trade-off can show up as shorter glove change intervals, more frequent seal replacement, earlier panel replacement, and a heavier preventive maintenance schedule. Over a decade of operation, that can be a substantial cost, and it rarely appears in the capital comparison.
There are technical trade-offs within the cycle as well. Micro-condensation approaches may achieve kill faster while aerating more slowly than dry-vapor systems, because the condensed film that improves sporicidal efficacy also creates a larger reservoir to remove. An advantage in one phase can be offset in another, and a headline number that reflects only the favorable phase will obscure that.
The number that actually matters
Cycle time is a proxy for what you actually care about, which is turnaround time between batches: cleaning, drying, loading, decontamination, aeration, particle recovery, line clearance, aseptic setup, and any documentation or release steps that sit between the end of one batch and the start of the next. On fast systems the fixed overheads often dominate, so the difference between competing cycle claims may be a small fraction of real turnaround.
A ten-minute difference in cycle time is only operationally meaningful if it changes how many batches fit into a shift pattern or campaign. Model the full turnaround against your actual shift structure before treating cycle time as a differentiator; in many cases the decision should turn on robustness, load flexibility, and material compatibility instead.
The most useful step a buyer can take is also the simplest: issue every bidder the same template and require them to quote against it. At minimum it should specify the load list and pattern, the phase definitions and where the clock starts and stops, the aeration endpoint with sensor type and locations, the BI acceptance criteria and mapping, and the ambient conditions under which the cycle was demonstrated. Ask what supporting data the supplier is able to share, and at what stage of the process. Comparable numbers are worth far more than optimistic ones.
How a supplier answers these questions is an early and low-cost indicator of how they will work with you later, once the isolator is on your floor and the qualification schedule is under pressure. Transparency at the quotation stage often translates into fewer surprises during qualification.
